搜索临床试验以:5-氟尿嘧啶和干扰素
总计9472个结果
-
Horizon Pharma Ireland, Ltd., Dublin IrelandFriedreich's Ataxia Research Alliance完全的
-
M.D. Anderson Cancer CenterSchering-Plough; Eisai Inc.终止
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的
-
National Cancer Institute, MilanAssociazione Italiana per la Ricerca sul Cancro完全的
-
The First Hospital of Jilin University完全的
-
French Innovative Leukemia Organisation完全的
-
NovartisHuman Genome Sciences Inc.完全的
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)完全的
-
Singapore National Eye CentreSingapore Eye Research Institute; Nanchang University完全的
-
Peking Union Medical College Hospital招聘中
-
Emory UniversityCURE Childhood Cancer, Inc.完全的
-
Institute of Cancer Research, United Kingdom完全的
-
Hackensack Meridian HealthNational Cancer Institute (NCI)撤销
-
Mongolian National University of Medical SciencesMongolian National Cancer Center招聘中
-
Children's Hospital of PhiladelphiaFriedreich's Ataxia Research Alliance; Vidara Therapeutics Research Ltd完全的
-
National Eye Institute (NEI)The Emmes Company, LLC完全的
-
Horizon Pharma Ireland, Ltd., Dublin IrelandFriedreich's Ataxia Research Alliance完全的
-
UNC Lineberger Comprehensive Cancer Center主动,不招人
-
University of North Carolina, Chapel HillTibotec Pharmaceutical Limited完全的
-
Dermatologic Cooperative Oncology Group未知治疗 | 佐剂 | III期恶性黑色素瘤 | Interferon Alpha德国
-
University Hospital TuebingenDermatologic Cooperative Oncology Group完全的
-
BiogenElan Pharmaceuticals终止复发缓解型多发性硬化症美国, 捷克共和国, 意大利, 西班牙, 瑞典, 拉脱维亚, 芬兰, 匈牙利, 波兰, 斯洛文尼亚, 澳大利亚, 加拿大, 法国
-
Merck KGaA, Darmstadt, GermanyMerck spol.s.r.o., Czech Republic完全的